about
Leptin signals via TGFB1 to promote metastatic potential and stemness in breast cancer.Mice deficient in the putative phospholipid flippase ATP11C exhibit altered erythrocyte shape, anemia, and reduced erythrocyte life span.The use of fluorescent target arrays for assessment of T cell responses in vivoLipo-chitin oligosaccharides, plant symbiosis signalling molecules that modulate mammalian angiogenesis in vitroSynthesis and preliminary evaluation of 5,7-dimethyl-2-aryl-3H-pyrrolizin-3-ones as angiogenesis inhibitors.Antiangiogenic platinum through glycan targeting.Heparan sulfate: a ubiquitous glycosaminoglycan with multiple roles in immunityHeparan sulfate as a receptor for poxvirus infections and as a target for antiviral agents.Developing Neolignans as Proangiogenic Agents: Stereoselective Total Syntheses and Preliminary Biological Evaluations of the Four Guaiacylglycerol 8-O-4'-Coniferyl Ethers.Extracellular histones induce erythrocyte fragility and anemia.Loss of intra-islet heparan sulfate is a highly sensitive marker of type 1 diabetes progression in humans.Activation of tumour cell ECM degradation by thrombin-activated platelet membranes: potentially a P-selectin and GPIIb/IIIa-dependent process.Targeted therapies in the management of locally advanced and metastatic pancreatic cancer: a systematic review.Promotion of mammalian angiogenesis by neolignans derived from soybean extracellular fluids.Melanoma protective antitumor immunity activated by catalytic DNAWhole-exome sequencing in evaluation of patients with venous thromboembolismPhase I trial of Lipovaxin-MM, a novel dendritic cell-targeted liposomal vaccine for malignant melanomaIs host heparanase required for the rapid spread of heparan sulfate binding viruses?
P50
Q33728621-625FC3F1-A819-44F7-87C0-3E2AEF280667Q33888560-C9F1B9BB-55E9-477D-BB99-93BD602DA5AAQ34331731-47085036-002F-49A4-B28A-DAF17B8C5D4CQ34764528-E8404F54-B0CD-4ADD-96D5-71083DDAF8A1Q35934934-191E1774-E077-47C6-9996-1E09AB4D24B5Q36357296-B5D0717F-5B39-4041-B997-5325FD4777CAQ37400143-940810DC-CBCB-472A-9281-806BC6C7606CQ41933064-2BE954A9-3548-4FE8-A3B0-C156C0D5CE6FQ47112532-43F8BA3E-C714-47DA-B9AC-21F9AF243B12Q49525696-ACC09C26-9011-4692-BF29-C031E16B9346Q50133247-8DF68102-FC81-4A58-AC3F-97721FABACEEQ53502283-47B7762C-691A-49AC-BCA9-72DA0CB52D55Q54974100-9C4A484D-21A2-43DC-80D1-A1E915F127CAQ55073573-B2E32A0C-4C8C-4B5A-8E55-87DB2E24CF53Q88911029-117F8ACC-9B56-47F7-A044-A3B6C6C3E88BQ89777077-18B41EAA-FD7A-433F-BF33-530984806FCFQ90264736-B4573DAD-11DA-4D65-B8D2-D9C15291F6E5Q90948634-819DFF65-56B8-41F2-AA2F-8A54CE6F6F01
P50
description
researcher
@en
wetenschapper
@nl
name
Christopher R Parish
@en
Christopher R Parish
@nl
type
label
Christopher R Parish
@en
Christopher R Parish
@nl
prefLabel
Christopher R Parish
@en
Christopher R Parish
@nl
P31
P496
0000-0001-7740-0430